He further hailed the close cooperation among ministries of health, agricultural Jihad, and the Central Bank of Iran (CBI) in this program and hoped that by the end of the last human testing phase, the launching of the mass production line of the vaccine, too, will take place.

The professor said that prior to the human testing phases, this vaccine was tested on a large number of animals, with very satisfactory results, and hoped the same results will be achieved in the last phase of its human testing.

According to the official, 133 people volunteered in the 1st phase of the human trial phase, 13 of whom received the vaccine initially while the rest had it according to a gradual time schedule.

“The next phase started a week later on a larger group, subdivided into four test groups, and 23 days’ time-lapse was given in this phase, after which the smelling phase of the vaccine began 30 days later,” said Dr. Fallah.

He said that after the successful end of that first phase and receiving the approval of the health ministry, tests on 500 human volunteers began in two 250-people sub-groups, and in this final phase a huge number of volunteers in Iran’s various provinces are involved.

The human trial of Razi-Covo Pars Covid19 Vaccine, which is the first Iranian injection-smelling new-formula protein Corona compound, has reached its final phase under the supervision of Agricultural Jihad Minister Kazem Khavazi, Head of Iranian Medical Science University Jalil Kouhpayeh, and a number of officials and researchers of Rasul-e Akram Hospital.

The method applied in the production of this vaccine is in accordance with the World Health Organization (WHO) routine.

The post Vaccine mass production line approved appeared first on Iran News Daily.

“This vaccine has been produced under the direct supervision of the Iranian Ministry of Health and in full cooperation with the Medical Equipment Department,” he said, “We hope to successfully pass the 1st and 2nd-in-human trials.”

his Institute began its activities in the year 1925 by producing a vaccine against Rinderpest under the supervision of the Ministry of Agriculture. Rinderpest at the time had caused large casualties in the cattle population of the country, but the Razi institute team very rapidly took up the research and production of the Rinderpest vaccine.

Iran will begin COVID-19 vaccination rollout this week, President Hassan Rouhani announced on Saturday, two days after the first shipment of Russian-made Sputnik V vaccine arrived in Tehran.

The announcement comes amid fears of a fourth wave of the coronavirus that was first reported in Iran in February last year, marking one year of the pandemic.

The first shipment of Sputnik V vaccine, the only foreign vaccine to be registered and approved in Iran, arrived by Iran’s Mahaan Airlines on Thursday.

In the first phase of vaccination, Rouhani said high-risk groups including healthcare workers on the frontline, followed by the elderly and those with critical ailments, will be administered the vaccine.

He said the vaccination program for the entire population of 80 million will take around eight months, as the second shipment of the Russian vaccine is expected to arrive by late February.

The post Iran unveils new COVID vaccine: ‘Razi Covo-Pars’ appeared first on Iran News Daily.